LeslieREllisMDMSHPEd, FACP(She/Her)
Oncology • Winston Salem, NCHematologic Oncology
Associate Professor, Internal Medicine, Bowman Gray School of Medicine of Wake Forest Univ
Dr. Ellis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Medical Center Blvd
Winston Salem, NC 27157Phone+1 336-716-4759
Summary
- Dr. Leslie Ellis is an oncologist in Winston-Salem, NC and is affiliated with Wake Forest Baptist Medical Center. She received her medical degree from University of North Carolina School of Medicine and has been in practice 17 years. She specializes in hematologic oncology.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
University of MichiganResidency, Internal Medicine, 2000 - 2003
University of North Carolina at Chapel Hill School of MedicineClass of 2000
Certifications & Licensure
NC State Medical License 2006 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia
- Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Publications & Presentations
PubMed
- 1 citationsConsensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency.Matthew L Chase, Reed Drews, Marc S Zumberg, Leslie R Ellis, Erin G Reid
Blood Advances. 2023-07-11 - 1 citationsReal-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen.Daniel R Reed, Margaux Wooster, Scott Isom, Leslie R Ellis, Dianna S Howard
Annals of Hematology. 2023-04-01 - 16 citationsPhase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia.Rebecca Anderson, Lance D Miller, Scott Isom, Jeff W Chou, Kristin M Pladna
Nature Communications. 2022-03-30
Abstracts/Posters
- Selinexor in Combination with Induction and Consolidation Therapy in Older Adults with AML Is Highly ActiveClinically Relevant AbstractLeslie Renee Ellis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Evaluating the Utilization of All-Trans Retinoic Acid and Arsenic Trioxide during Consolidation Therapy for Patients Receiving Treatment for Acute Promyelocytic LeukemiaLeslie Renee Ellis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Benefits with Gilteritinib for AML Were Maintained, Regardless of Co-MutationsJune 4th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
